Improvement of psoriasis vulgaris after intralesional injections of 15-hydroxyeicosatetraenoic acid (15-HETE)
- 29 February 1988
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 18 (2), 279-285
- https://doi.org/10.1016/s0190-9622(88)70040-7
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Dermis-Derived 15-Hydroxy-eicosatertraenoic Acid Inhibits Epidermal 12-Lipoxygenase ActivityJournal of Investigative Dermatology, 1986
- Epidermal hyperproliferation following the induction of microabscesses by leukotriene B4British Journal of Dermatology, 1986
- Leukotrienes B4, C4 and D4 stimulate DNA synthesis in cultured human epidermal keratinocytesBritish Journal of Dermatology, 1985
- Cutaneous Responses to 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid (12-HETE)Journal of Investigative Dermatology, 1985
- Leukotrienes C4 and D4 psoriatic skin lesionsProstaglandins, 1985
- The Release of Leukotriene B4-like Material in Biologically Active Amounts from the Lesional Skin of patients with PsoriasisJournal of Investigative Dermatology, 1984
- Production of Intraepidermal Microabscesses by Topical Application of Leukotriene B4Journal of Investigative Dermatology, 1984
- Local Effects of Synthetic Leukotrienes (LTC4, LTD4, and LTB4) in Human SkinJournal of Investigative Dermatology, 1983
- Selective feed-back inhibition of the 5-lipoxygenation of arachidonic acid in human T-lymphocytesBiochemical and Biophysical Research Communications, 1981
- Cyclosporin a for PsoriasisNew England Journal of Medicine, 1979